Production (Stage)
Innovation1 Biotech Inc.
IVBT
$0.005
$0.00482,400.00%
OTC PK
| 02/29/2024 | 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.30M | -5.61M | -5.99M | -38.78M | -40.09M |
| Total Depreciation and Amortization | 1.20K | 1.20K | 52.80K | 829.20K | 1.73M |
| Total Amortization of Deferred Charges | 221.30K | 113.90K | 22.30K | 22.30K | 22.30K |
| Total Other Non-Cash Items | 3.74M | 4.02M | 4.02M | 36.19M | 36.04M |
| Change in Net Operating Assets | 822.60K | 901.00K | 1.27M | 664.40K | 740.00K |
| Cash from Operations | -515.40K | -575.90K | -620.20K | -1.07M | -1.56M |
| Capital Expenditure | -- | -- | -- | -500.00K | -500.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 500.00K | 500.00K |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | 570.50K | 570.50K | 513.60K | 513.60K | -3.70M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 4.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 570.50K | 570.50K | 513.60K | 513.60K | 300.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | 55.00K | -5.50K | -106.70K | -559.50K | -1.26M |